211 related articles for article (PubMed ID: 15056447)
21. Efficacy of amenamevir for the treatment of herpes zoster in an immunocompromised patient: Report of a case.
Ishiguro A; Takama H; Yanagishita T; Ohshima Y; Watanabe D
J Dermatol; 2019 Aug; 46(8):e270-e271. PubMed ID: 30897230
[No Abstract] [Full Text] [Related]
22. Antiviral drugs for varicella-zoster virus and herpes simplex virus infections.
Med Lett Drugs Ther; 2018 Sep; 60(1556):153-157. PubMed ID: 30383727
[No Abstract] [Full Text] [Related]
23. Compartmentalization of acyclovir-resistant varicella zoster virus: implications for sampling in molecular diagnostics.
Brink AA; van Gelder M; Wolffs PF; Bruggeman CA; van Loo IH
Clin Infect Dis; 2011 Apr; 52(8):982-7. PubMed ID: 21460310
[TBL] [Abstract][Full Text] [Related]
24. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Reusser P
J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
[TBL] [Abstract][Full Text] [Related]
25. Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy.
Linnemann CC; Biron KK; Hoppenjans WG; Solinger AM
AIDS; 1990 Jun; 4(6):577-9. PubMed ID: 2167103
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
27. Acyclovir-resistant varicella zoster responsive to foscarnet.
Smith KJ; Kahlter DC; Davis C; James WD; Skelton HG; Angritt P
Arch Dermatol; 1991 Jul; 127(7):1069-71. PubMed ID: 1648341
[No Abstract] [Full Text] [Related]
28. Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.
Hatchette T; Tipples GA; Peters G; Alsuwaidi A; Zhou J; Mailman TL
Pediatr Infect Dis J; 2008 Jan; 27(1):75-7. PubMed ID: 18162946
[TBL] [Abstract][Full Text] [Related]
29. Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy.
Breton G; Fillet AM; Katlama C; Bricaire F; Caumes E
Clin Infect Dis; 1998 Dec; 27(6):1525-7. PubMed ID: 9868672
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
Bleymehl K; Cinatl J; Schmidt-Chanasit J
Med Microbiol Immunol; 2011 Aug; 200(3):193-202. PubMed ID: 21373931
[TBL] [Abstract][Full Text] [Related]
31. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
Sergerie Y; Boivin G
Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252
[TBL] [Abstract][Full Text] [Related]
32. Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
Lateef F; Don PC; Kaufmann M; White SM; Weinberg JM
Arch Dermatol; 1998 Sep; 134(9):1169-70. PubMed ID: 9762047
[No Abstract] [Full Text] [Related]
33. Longitudinal analysis of varicella-zoster virus DNA on the ocular surface associated with herpes zoster ophthalmicus.
Zaal MJ; Völker-Dieben HJ; Wienesen M; D'Amaro J; Kijlstra A
Am J Ophthalmol; 2001 Jan; 131(1):25-9. PubMed ID: 11162975
[TBL] [Abstract][Full Text] [Related]
34. Chorioretinitis with exudative retinal detachment secondary to varicella zoster virus.
Le TD; Weisbrod D; Mandelcorn ED
Can J Ophthalmol; 2015 Oct; 50(5):e91-3. PubMed ID: 26455991
[No Abstract] [Full Text] [Related]
35. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
[TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
Garré B; van der Meulen K; Nugent J; Neyts J; Croubels S; De Backer P; Nauwynck H
Vet Microbiol; 2007 May; 122(1-2):43-51. PubMed ID: 17276631
[TBL] [Abstract][Full Text] [Related]
37. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.
Levin MJ; Dahl KM; Weinberg A; Giller R; Patel A; Krause PR
J Infect Dis; 2003 Oct; 188(7):954-9. PubMed ID: 14513413
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
Lalezari J; Schacker T; Feinberg J; Gathe J; Lee S; Cheung T; Kramer F; Kessler H; Corey L; Drew WL; Boggs J; McGuire B; Jaffe HS; Safrin S
J Infect Dis; 1997 Oct; 176(4):892-8. PubMed ID: 9333146
[TBL] [Abstract][Full Text] [Related]
39. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
40. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
Muluneh B; Dean A; Armistead P; Khan T
J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
